| 000 | 01469 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513091659.0 | ||
| 264 | 0 | _c19960801 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKozaki, K | |
| 245 | 0 | 0 |
_aWithdrawal or reduction of steroids based on pharmacodynamics assessed by antilymphocyte action after renal transplantation. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cJun 1996 |
||
| 300 |
_a1300-1 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCyclosporine _xpharmacokinetics |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aGraft Survival |
| 650 | 0 | 4 | _aHistocompatibility Testing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aMethylprednisolone _xadministration & dosage |
| 650 | 0 | 4 |
_aPrednisolone _xadministration & dosage |
| 650 | 0 | 4 |
_aRibonucleosides _xtherapeutic use |
| 700 | 1 | _aTakeuchi, H | |
| 700 | 1 | _aHirano, T | |
| 700 | 1 | _aOka, K | |
| 700 | 1 | _aSakurai, E | |
| 700 | 1 | _aUchiyama, M | |
| 700 | 1 | _aMatsuno, N | |
| 700 | 1 | _aYoshida, M | |
| 700 | 1 | _aKozaki, M | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 28 _gno. 3 _gp. 1300-1 |
|
| 999 |
_c8657704 _d8657704 |
||